Director, Center for Advanced Coronary Interventions
Minneapolis Heart Institute
Minneapolis, Minnesota, United States
Emmanouil S. Brilakis is Director of the Center for Advanced Coronary Interventions at the Minneapolis Heart Institute. He leads a clinical trial group investigating treatment of chronic total occlusions, saphenous vein graft disease, intracoronary imaging, lipid lower strategies, antiplatelet treatment optimization post coronary stenting, radiation safety in the catheterization laboratory, and implementation of novel technologies in healthcare. Dr. Brilakis has authored or co-authored over 800 manuscripts and has written the Manual of PCI and the Manual of CTO Interventions now in its 3rd edition.
Saturday, February 25, 2023
8:00 AM – 12:22 PM ET
Disclosure(s): Abbott: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); amgen: Consultant/Advisory Board (Ongoing); Asahi Intecc, Japan: Honoraria (Ongoing); Biotronik: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cleerly Health: Shareholder (Ongoing); csi cardiovascular systems: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Elsevier: Royalties (Ongoing); GE Healthcare: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Hippocrates LLC: Owner/Co-Owner Founder/Co-Founder (Ongoing); IMDS: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medicure: Honoraria (Terminated); Medtronic: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); MHI Ventures: Shareholder (Ongoing); Siemens: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Stallion Medical: Shareholder (Ongoing); Teleflex: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Saturday, February 25, 2023
8:00 AM – 8:50 AM ET
Disclosure(s): Abbott: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); amgen: Consultant/Advisory Board (Ongoing); Asahi Intecc, Japan: Honoraria (Ongoing); Biotronik: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cleerly Health: Shareholder (Ongoing); csi cardiovascular systems: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Elsevier: Royalties (Ongoing); GE Healthcare: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Hippocrates LLC: Owner/Co-Owner Founder/Co-Founder (Ongoing); IMDS: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medicure: Honoraria (Terminated); Medtronic: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); MHI Ventures: Shareholder (Ongoing); Siemens: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Stallion Medical: Shareholder (Ongoing); Teleflex: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Saturday, February 25, 2023
9:06 AM – 9:14 AM ET
Disclosure(s): Abbott: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); amgen: Consultant/Advisory Board (Ongoing); Asahi Intecc, Japan: Honoraria (Ongoing); Biotronik: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cleerly Health: Shareholder (Ongoing); csi cardiovascular systems: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Elsevier: Royalties (Ongoing); GE Healthcare: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Hippocrates LLC: Owner/Co-Owner Founder/Co-Founder (Ongoing); IMDS: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medicure: Honoraria (Terminated); Medtronic: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); MHI Ventures: Shareholder (Ongoing); Siemens: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Stallion Medical: Shareholder (Ongoing); Teleflex: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Saturday, February 25, 2023
11:18 AM – 12:22 PM ET
Disclosure(s): Abbott: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); amgen: Consultant/Advisory Board (Ongoing); Asahi Intecc, Japan: Honoraria (Ongoing); Biotronik: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cleerly Health: Shareholder (Ongoing); csi cardiovascular systems: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Elsevier: Royalties (Ongoing); GE Healthcare: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Hippocrates LLC: Owner/Co-Owner Founder/Co-Founder (Ongoing); IMDS: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medicure: Honoraria (Terminated); Medtronic: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); MHI Ventures: Shareholder (Ongoing); Siemens: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Stallion Medical: Shareholder (Ongoing); Teleflex: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Sunday, February 26, 2023
2:00 PM – 5:30 PM ET
Disclosure(s): Abbott: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); amgen: Consultant/Advisory Board (Ongoing); Asahi Intecc, Japan: Honoraria (Ongoing); Biotronik: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cleerly Health: Shareholder (Ongoing); csi cardiovascular systems: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Elsevier: Royalties (Ongoing); GE Healthcare: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Hippocrates LLC: Owner/Co-Owner Founder/Co-Founder (Ongoing); IMDS: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medicure: Honoraria (Terminated); Medtronic: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); MHI Ventures: Shareholder (Ongoing); Siemens: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Stallion Medical: Shareholder (Ongoing); Teleflex: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Sunday, February 26, 2023
2:00 PM – 2:45 PM ET
Disclosure(s): Abbott: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); amgen: Consultant/Advisory Board (Ongoing); Asahi Intecc, Japan: Honoraria (Ongoing); Biotronik: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cleerly Health: Shareholder (Ongoing); csi cardiovascular systems: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Elsevier: Royalties (Ongoing); GE Healthcare: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Hippocrates LLC: Owner/Co-Owner Founder/Co-Founder (Ongoing); IMDS: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medicure: Honoraria (Terminated); Medtronic: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); MHI Ventures: Shareholder (Ongoing); Siemens: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Stallion Medical: Shareholder (Ongoing); Teleflex: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Sunday, February 26, 2023
2:45 PM – 2:53 PM ET
Disclosure(s): Abbott: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); amgen: Consultant/Advisory Board (Ongoing); Asahi Intecc, Japan: Honoraria (Ongoing); Biotronik: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cleerly Health: Shareholder (Ongoing); csi cardiovascular systems: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Elsevier: Royalties (Ongoing); GE Healthcare: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Hippocrates LLC: Owner/Co-Owner Founder/Co-Founder (Ongoing); IMDS: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medicure: Honoraria (Terminated); Medtronic: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); MHI Ventures: Shareholder (Ongoing); Siemens: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Stallion Medical: Shareholder (Ongoing); Teleflex: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Sunday, February 26, 2023
4:13 PM – 4:30 PM ET
Disclosure(s): Abbott: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); amgen: Consultant/Advisory Board (Ongoing); Asahi Intecc, Japan: Honoraria (Ongoing); Biotronik: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cleerly Health: Shareholder (Ongoing); csi cardiovascular systems: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Elsevier: Royalties (Ongoing); GE Healthcare: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Hippocrates LLC: Owner/Co-Owner Founder/Co-Founder (Ongoing); IMDS: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medicure: Honoraria (Terminated); Medtronic: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); MHI Ventures: Shareholder (Ongoing); Siemens: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Stallion Medical: Shareholder (Ongoing); Teleflex: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)